M&I faculty members Jeff Dangl and Beth Shank are featured in an article on how local biotech companies can benefit from UNC research aimed at understanding the plant microbiome and microbe-plant interactions. See the Endeavors Magazine story at the link below. The Business of Bugs

Congratulations to M&I Professors Stan Lemon and Jeff Dangl for earning the “Highly Cited Researchers” distinction from Thomson Reuters. The names on this list, determined from Web of Science publication and citation metrics, include scientists who have authored the greatest number of “highly cited papers” (the top 1% most cited for their subject field and … Read more

This next academic year will be the initiation of the new Translational Education at Carolina (TEC) curriculum for medical students, a fundamental change from the standard coursework stucture that has been in place for many years. Immunology will taught in an individual course, while microbiology/infectious disease teaching will be woven throughout a series of organ-based … Read more

In this new mBio article, systems biology meets viral pathogenesis as the Baric lab compares infections by highly pathogenic H5N1 avian influenza (HPAI) A virus, 2009 pandemic H1N1, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory syndrome CoV (MERS-CoV). They demonstrate the existence of unique and common viral strategies for controlling interferon-stimulated genes … Read more

A new PNAS article from Ralph Baric’s lab, in collaboration with Wayne Marasco’s group at the Dana-Farber Cancer Institute, describes the use of a human antibody-phage library to identify seven human neutralizing antibodies specific for the receptor-binding domain of the MERS-CoV Spike protein. See the UNC News article at the link below.   Immunological Study … Read more

M&I is one of 14 doctoral programs that are selected by students who have been admitted through one of two interdisciplinary portals: the Biological and Biomedical Sciences Program (BBSP) and the MD-PhD program. On Friday, May 16, eleven PhD students and two MD-PhD joined M&I and embarked on the dissertation phase of their predoctoral training. … Read more

After nearly 30 years on the UNC faculty, our friend and colleague Steve Clarke has decided to move to AbbVie in Worcester, MA, to pursue a new direction in his research on lupus. His lab is well known for many studies on B cell development, B cell tolerance, and loss of tolerance in disease. We … Read more

A UNC News article on PREP (Postbaccalaureate Research Education Program) includes comments from M&I alum Josh Hall (2008, Kawula lab), Director of this NIH-sponsored program. Three of the eight current PREP students are working in M&I labs this year: Hubaida Fuseini (Abel lab), Ninecia Scott (Braunstein lab), and Uduak Udoeyo (Miller lab). Prepped and ready … Read more

Congratulations to Ellen Perkowski, winner of the inaugural D. Gordon Sharp Graduate Innovator Award. As part of her dissertation work in Miriam Braunstein’s lab, Ellen has developed an innovative system for genome-wide identification of proteins exported by bacterial pathogens during infection. This system, which she has termed “Exported In vivo Technology (EXIT),” has a distinct … Read more

M&I graduate students Morgan Goheen and Martha Clark are featured in an Endeavors story on the complex issues related to iron supplements for treating malaria in Africa. See the article at the link below. Safer Supplements